Proactive Investors - Run By Investors For Investors

AusCann Group chairman buys $58,238 worth of shares on-market

The purchase follows the recent appointment to CEO of ex Teva Pharmaceutical executive, Ido Kanyon.
three empty board seats
The chairman is one of the company's largest shareholders

AusCann Group Holdings Ltd's (ASX:AC8) chairman Mal Washer has purchased 144,000 shares in the company valued at $58,238.

The purchase was completed via on-market trades and increases Washer's total holding in the company to 12.85 million shares.

Shares in the company last traded at 38 cents, a discount to Washer's average purchase price of 40.44 cents.

READ: AusCann Group appoints Teva Pharmaceutical executive as new CEO

Recently, AusCann appointed global pharmaceutical business executive Ido Kanyon, as its CEO commencing 22 May 2019.

Kanyon brings more than 15 years’ senior executive experience in the pharmaceutical industry most recently at multi-billion dollar Teva Pharmaceutical Industries Ltd (NYSE:TEVA).

Teva is the world's largest generic pharmaceutical company which also specialised in the development and commercialisation of active pharmaceutical ingredients and specialty proprietary medicines.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full AC8 profile View Profile

AusCann Group Holdings Ltd Timeline

Related Articles

cannabis plant
May 05 2019
The cannabis company invests in income-producing property and provides financing solutions and capital investment to service the blossoming cannabis industry
cannabis
August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
1541165310_canadian-flag-1.jpg
November 02 2018
Back Home Medical Cannabis Corp has agreed on a 24,000-kilogram three-year production and supply agreement
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use